Literature DB >> 35094332

Molecular Imaging of HER2 in Patient Tissues with Touch Prep-Quantitative Single Molecule Localization Microscopy.

Devin L Wakefield1,2, Steven J Tobin1, Daniel Schmolze3, Tijana Jovanovic-Talisman4.   

Abstract

Biomolecules can be investigated at the nanoscale with quantitative single molecule localization microscopy (qSMLM). This technique, which achieves single molecule sensitivity, can probe how membrane receptors are organized under both normal and pathological conditions. While a number of receptors have been extensively studied in cultured cells, technical challenges have largely impeded their robust quantification in tissue samples. To rigorously interrogate tissue samples, methodological advancements are needed in three areas: analytical preparation of the sample, proper characterization of fluorescent reporters, and rapid/unbiased data analysis. Towards these ends, we have combined qSMLM with a touch preparation technique (touch prep-qSMLM). In this new method, touch prep is first used to obtain monolayers of patient cells. Then, highly selective, fluorescently labeled probes are used to detect the receptors of interest on the plasma membranes of cells. Finally, quantitative algorithms are used to analyze the imaging data. Using this touch prep-qSMLM methodology, we interrogated the density and nano-organization of human epidermal growth factor receptor 2 (HER2) in fresh breast cancer tissues. Touch prep-qSMLM agreed well with current clinical methods. Importantly, touch prep-qSMLM can be easily extended to other pathological conditions and ultimately used in precision medicine.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breast cancer; Human epidermal growth factor receptor 2; MATLAB data analysis; Quantitative single molecule localization microscopy; Touch preparation

Mesh:

Substances:

Year:  2022        PMID: 35094332      PMCID: PMC9121336          DOI: 10.1007/978-1-0716-1811-0_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  41 in total

1.  Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM).

Authors:  Michael J Rust; Mark Bates; Xiaowei Zhuang
Journal:  Nat Methods       Date:  2006-08-09       Impact factor: 28.547

Review 2.  Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer.

Authors:  Rita Nahta; Dihua Yu; Mien-Chie Hung; Gabriel N Hortobagyi; Francisco J Esteva
Journal:  Nat Clin Pract Oncol       Date:  2006-05

3.  Probing protein heterogeneity in the plasma membrane using PALM and pair correlation analysis.

Authors:  Prabuddha Sengupta; Tijana Jovanovic-Talisman; Dunja Skoko; Malte Renz; Sarah L Veatch; Jennifer Lippincott-Schwartz
Journal:  Nat Methods       Date:  2011-09-18       Impact factor: 28.547

Review 4.  Treatment of HER2-positive breast cancer: current status and future perspectives.

Authors:  Carlos L Arteaga; Mark X Sliwkowski; C Kent Osborne; Edith A Perez; Fabio Puglisi; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2011-11-29       Impact factor: 66.675

Review 5.  Improving treatment of HER2-positive cancers: opportunities and challenges.

Authors:  Howard M Stern
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

6.  Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Authors:  M F Press; G Hung; W Godolphin; D J Slamon
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

7.  STED super-resolution microscopy of clinical paraffin-embedded human rectal cancer tissue.

Authors:  Peter Ilgen; Stefan Stoldt; Lena-Christin Conradi; Christian Andreas Wurm; Josef Rüschoff; B Michael Ghadimi; Torsten Liersch; Stefan Jakobs
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

8.  Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D ) in the plasma membrane at the nanoscale level.

Authors:  Maciej K Rogacki; Ottavia Golfetto; Steven J Tobin; Tianyi Li; Sunetra Biswas; Raphael Jorand; Huiying Zhang; Vlad Radoi; Yu Ming; Per Svenningsson; Daniel Ganjali; Devin L Wakefield; Athanasios Sideris; Alexander R Small; Lars Terenius; Tijana Jovanović-Talisman; Vladana Vukojević
Journal:  Traffic       Date:  2018-05-28       Impact factor: 6.215

9.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

10.  ClusterViSu, a method for clustering of protein complexes by Voronoi tessellation in super-resolution microscopy.

Authors:  Leonid Andronov; Igor Orlov; Yves Lutz; Jean-Luc Vonesch; Bruno P Klaholz
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

View more
  1 in total

1.  Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer.

Authors:  Adam L Maddox; Matthew S Brehove; Kiarash R Eliato; Andras Saftics; Eugenia Romano; Michael F Press; Joanne Mortimer; Veronica Jones; Daniel Schmolze; Victoria L Seewaldt; Tijana Jovanovic-Talisman
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.